Literature DB >> 17473947

Topiramate-induced restless legs syndrome: a report of two cases.

Andrea Romigi, Francesca Izzi, Fabio Placidi, Francesca Sperli, Angela Cervellino, Maria Grazia Marciani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17473947     DOI: 10.1007/s00415-007-0243-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  8 in total

1.  Topiramate selectively attenuates nicotine-induced increases in monoamine release.

Authors:  W K Schiffer; M R Gerasimov; D A Marsteller; J Geiger; C Barnett; D L Alexoff; S L Dewey
Journal:  Synapse       Date:  2001-12-01       Impact factor: 2.562

Review 2.  The restless legs syndrome and periodic limb movement disorder: a review of management.

Authors:  Suzanne Lesage; Wayne A Hening
Journal:  Semin Neurol       Date:  2004-09       Impact factor: 3.420

3.  Pilot trial of lamotrigine in the restless legs syndrome.

Authors:  Eriene A Youssef; Mary L Wagner; Jaime O Martinez; Wayne Hening
Journal:  Sleep Med       Date:  2004-12-25       Impact factor: 3.492

Review 4.  Topiramate monotherapy in epilepsy and migraine prevention.

Authors:  Stephen D Silberstein; Elinor Ben-Menachem; Richard P Shank; Frank Wiegand
Journal:  Clin Ther       Date:  2005-02       Impact factor: 3.393

Review 5.  New paradigms in the treatment of restless legs syndrome.

Authors:  Michael J Thorpy
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

6.  Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome.

Authors:  Arthur S Walters; Cheryl LeBrocq; Anjana Dhar; Wayne Hening; Ray Rosen; Richard P Allen; Claudia Trenkwalder
Journal:  Sleep Med       Date:  2003-03       Impact factor: 3.492

Review 7.  Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?

Authors:  Bankole A Johnson
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

8.  Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid.

Authors:  Ilonka Eisensehr; Bruce L Ehrenberg; Silvia Rogge Solti; Soheyl Noachtar
Journal:  J Neurol       Date:  2004-05       Impact factor: 4.849

  8 in total
  3 in total

1.  Restless legs syndrome induced by topiramate: two more cases.

Authors:  Pedro Emilio Bermejo
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

Review 2.  [Restless legs syndrome, periodic limb movements, and psychopharmacology].

Authors:  S Cohrs; A Rodenbeck; M Hornyak; D Kunz
Journal:  Nervenarzt       Date:  2008-11       Impact factor: 1.214

3.  Topiramate-induced periodic limb movement disorder in a patient affected by focal epilepsy.

Authors:  Andrea Romigi; Giuseppe Vitrani; Alfredo D'Aniello; Giancarlo Di Gennaro
Journal:  Epilepsy Behav Case Rep       Date:  2014-05-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.